A mutational signature in gastric cancer suggests therapeutic strategies

Nature Communications

Volumn 6, Issue , 2015, Pages

  Alexandrov, Ludmil B ^a,b,c   Nik Zainal, Serena ^a,d   Siu, Hoi Cheong ^e   Leung, Suet Yi ^e   Stratton, Michael R ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c CENTER FOR NONLINEAR STUDIES   (United States)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; DISEASE TREATMENT; GENE EXPRESSION; GENOME; MUTATION;

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST TUMOR; DNA REPAIR; DNA STRAND BREAKAGE; FEMALE; GENETICS; HUMAN; MALE; MUTATION; NEOPLASM; PANCREAS TUMOR; STOMACH TUMOR;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA BREAKS; DNA REPAIR; FEMALE; HUMANS; MALE; MUTATION; NEOPLASMS; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS;

EID: 84946120134     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9683     Document Type: Article

References (31)

1. Ford, D. et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 62, 676-689 (1998)
2. King, M. C., Marks, J. H. & Mandell, J. B. New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302, 643-646 (2003)
3. Risch, H. A. et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am. J. Hum. Genet. 68, 700-710 (2001)
4. Greer, J. B. & Whitcomb, D. C. Role of BRCA1 and BRCA2 mutations in pancreatic cancer. Gut 56, 601-605 (2007)
5. Merajver, S. D. et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet. 9, 439-443 (1995)
6. Miki, Y., Katagiri, T., Kasumi, F., Yoshimoto, T. & Nakamura, Y. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet. 13, 245-247 (1996)
7. Jackson, S. P. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23, 687-696 (2002)
8. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012)
9. Walsh, T. et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295, 1379-1388 (2006)
10. Rottenberg, S. et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc. Natl Acad. Sci. USA 105, 17079-17084 (2008)
11. Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917-921 (2005)
12. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013)
13. Alexandrov, L. B. & Stratton, M. R. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr. Opin. Genet. Dev. 24, 52-60 (2014)
14. Helleday, T., Eshtad, S. & Nik-Zainal, S. Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15, 585-598 (2014)
15. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246-259 (2013)
16. Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495-501 (2015)
17. Wang, K. et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46, 573-582 (2014)
18. Zang, Z. J. et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat. Genet. 44, 570-574 (2012)
19. Wang, K. et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat. Genet. 43, 1219-1223 (2011)
20. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202-209 (2014)
21. Ferlay, J. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917 (2010)
22. Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001)
23. Abecasis, G. R. et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 491, 56-65 (2012)
24. Fu, W. et al. Analysis of 6, 515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216-220 (2013)
25. Dreszer, T. R. et al. The UCSC Genome Browser database: extensions and updates 2011. Nucleic Acids Res. 40, D918-D923 (2012)
26. Behjati, S. et al. Genome sequencing of normal cells reveals developmental lineages and mutational processes. Nature 513, 422-425 (2014)
27. Bolli, N. et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat. Commun. 5, 2997 (2014)
28. Ju, Y. S. et al. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer eLife. http://dx. doi. org/10. 7554/eLife. 02935 (2014)
29. Murchison, E. P. et al. Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage. Science 343, 437-440 (2014)
30. Nik-Zainal, S. et al. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat. Genet. 46, 487-491 (2014)
31. Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225-233 (2014)